Skip to main content
Toggle navigation
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
Tamariz-Amador, Luis-Esteban
Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IdiSNA
OA-11: Utility of 18FDG-PET/CT for Risk Prediction in Relapsed/Refractory Multiple Myeloma Patients Undergoing CAR-T Cell Therapy: Analysis of Baseline and Early Assessment Scans After One and Three Months
Location: Trianti
Luis-Esteban Tamariz-Amador
tan, wei
The University of Texas MD Anderson Cancer Center
OA-36: sBCMA predicts progression and is a biomarker of response in myeloma precursor disease followed on prospective studies
Location: Mitropoulas
wei tan
Terpos, Evangelos
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece
Optimizing supportive care management
Location: Trianti
Evangelos Terpos
Striking the balance: challenges in myeloma supportive care
Location: MC3
Evangelos Terpos
Tiedemann, Rodger
Princess Margaret Cancer Centre
OA-25: MM B cells and pre-plasma cell progenitors are the cellular origin of MM disease relapse following effective therapy targeting plasma cells
Location: Trianti
Rodger Tiedemann
Round table discussion
Location: Trianti
Rodger Tiedemann
Touzeau, Cyrille
CHU Nantes
OA-54: Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone with tandem transplant in high-risk newly diagnosed myeloma patients: final results of the phase 2 study IFM 2018-04
Location: Skalkotas
Cyrille Touzeau
Treon, Steven
Dana Farber Cancer Institute
Waldenstrom
Location: Trianti
Steven Treon
Trudel, Suzanne
Princess Margaret Cancer Centre, Toronto, ON, Canada
Meet the Professor: Approaches to MRD assessment
Location: MR1
Suzanne Trudel
Tsatsou, Ioanna
7th Nursing & Allied Health Symposium - A Sprint and a Marathon: Building Resilience
Location: MC3
Ioanna Tsatsou
Open
Location: MC3
Ioanna Tsatsou
